Publication

Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.

Journal Paper/Review - Sep 22, 2023

Units
PubMed
Doi
Contact

Citation
Manuel O, Laager M, Hirzel C, Neofytos D, Walti L, Hönger G, Binet F, Schnyder A, Stampf S, Koller M, Mombelli M, Kim M, Hoffmann M, Koenig K, Hess C, Burgener A, Cippà P, Hübel K, Müller T, Sidler D, Dahdal S, Suter-Riniker F, Villard J, Zbinden A, Pantaleo G, Semmo N, Hadaya K, Enriquez N, Meylan P, Froissart M, Golshayan D, Fehr T, Huynh-Do U, Pascual M, Van Delden C, Hirsch H, Jüni P, Müller N, Swiss Transplant Cohort Study (STCS). Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial. Clin Infect Dis 2023
Type
Journal Paper/Review (English)
Journal
Clin Infect Dis 2023
Publication Date
Sep 22, 2023
Issn Electronic
1537-6591
Brief description/objective

The use of assays detecting cytomegalovirus (CMV)-specific T-cell-mediated immunity may individualize the duration of antiviral prophylaxis in transplant recipients.